Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Latex Hypersensitivity
Patient Acceptance of Health Care
Sattar, Husain
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia. EBioMedicine. 2015 Apr; 2(4):284.
View in:
PubMed
subject areas
Adrenergic beta-2 Receptor Agonists
Cholesterol, LDL
Dyslipidemias
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Targeted Therapy
authors with profiles
Michael Davidson